aTyr Pharma News and Activities

aTyr Pharma is a company listed under the stock ticker ATYR (US).

View the org chart displaying its 19 main executives

Most searched biographies at aTyr Pharma

• Sanjay Shukla, President, Chief Executive Officer and Director
• Sara Zaknoen, Director
• Svetlana Lucas, Director

Popular executive movements at aTyr Pharma

• Dalia Rayes has joined the company as Head of Commercial, Global Efzofitimod Franchise  (posted on March 28 2025).
• Eric Benevich has joined the company as Director  (posted on December 18 2024).

Create your alert
to follow the executive moves at aTyr Pharma.

aTyr Pharma has 1,827 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• Danone has announced the acquisition of Kate Farms  (posted on May 14 2025).
• Cyclo Therapeutics has acquired Rafael Holdings (posted on April 28 2025).
• Chimerix and Chimerix have merged  (posted on April 22 2025)..

Popular contacts in Pharmaceuticals

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets at Bristol-Myers Squibb
• Seth Harrison - Chairman and Director at Braeburn Pharmaceuticals
• Fred Davenport - Lead Director at Medpace

Learn more about the Pharmaceuticals industry

Press releases by aTyr Pharma

• aTyr Pharma to Present at Life Sciences Investor Forum on September 17th
• aTyr Pharma to Participate in October Virtual Investor Events | aTyr Pharma
• aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Doses First Subjects in Phase 1 Trial of ATYR1923 in Japan | aTyr Pharma
• aTyr Pharma Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC | aTyr Pharma
• aTyr Pharma to Present at September Investor Conferences | aTyr Pharma
• aTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial Programs | aTyr Pharma
• aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan | aTyr Pharma
• aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2020 Financial Results | aTyr Pharma
• aTyr Pharma Presents Preclinical Research Showing NRP2 Antibody Effects in Triple-Negative Breast Cancer at the 2020 AACR Virtual Annual Meeting II | aTyr Pharma
• aTyr Pharma Highlights New Literature Implicating Neuropilin Pathway In SARS-CoV-2 Infection | aTyr Pharma
• View more press releases Close

Social media about aTyr Pharma

• aTyr Pharma on Wikipedia, Google News & Yahoo Finance
• aTyr Pharma on LinkedIn, Twitter & YouTube